New psoriatic arthritis drug shows promise in Mid-Stage trial
NCT ID NCT07321873
First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 4 times
Summary
This study tests whether the experimental drug JNJ-88545223 can reduce joint pain, swelling, and skin symptoms in adults with active psoriatic arthritis. About 240 participants will receive either the drug or a placebo to see if it works better than no treatment. The goal is to improve joint and skin health over 16 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 240 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Have a diagnosis of psoriatic arthritis (PsA) for at least 3 months before the first administration of study intervention and meet classification criteria for Psoriatic Arthritis (CASPAR) at screening * Have active PsA as defined by: (a) At least 3 swollen joints and at least 3 tender joints at screening and at baseline (Week 0/Day 1) based on the 66/68 joint assessment; AND (b) C-reactive protein (CRP) greater than or equal to (\>=) 0.1 milligrams per deciliter (mg/dL) at screening from the central laboratory * Have \>= 1 of the following PsA subsets: distal interphalangeal joint involvement, polyarticular arthritis with absence of rheumatoid nodules, asymmetric peripheral arthritis, or spondylitis with peripheral arthritis * Have active plaque psoriasis with at least one psoriatic plaque of \>= 2 centimeter (cm) diameter or nail changes consistent with psoriasis * A female participant of childbearing potential must have a negative highly sensitive serum pregnancy test (Beta-hCG) at screening and a negative urine pregnancy test at Week 0 prior to administration of study intervention Exclusion Criteria: * Has a nonplaque form of psoriasis (for example, erythrodermic, guttate, or pustular) * Has a history or current signs or symptoms of severe, progressive, or uncontrolled renal, hepatic, cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic (except PsA), psychiatric, genitourinary, or metabolic disturbances * Has suspected or known allergies, hypersensitivity, or intolerance to JNJ-88545223 or excipients used in the investigational medicinal product (IMP), including placebo (JNJ-88545223 investigator's brochure); or has a history of severe allergic reaction, angioedema, or anaphylaxis to drugs or food * Has fibromyalgia or osteoarthritis symptoms that, in the opinion of the investigator, would have potential to interfere with efficacy assessments * Currently has a malignancy or has a history of malignancy within 5 years prior to screening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthritis, psoriatic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
73 sites in 8 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Albuquerque Rehabilitation and Rheumatology
RECRUITINGAlbuquerque, New Mexico, 87102, United States
-
American Research, LLC
RECRUITINGCutler Bay, Florida, 33157, United States
-
Arthritis and Rheumatology Research Institute
RECRUITINGFrisco, Texas, 75035, United States
-
Atlanta Research Center for Rheumatology
RECRUITINGMarietta, Georgia, 30060, United States
-
Beijing Tsinghua Changgung Hospital
RECRUITINGBeijing, 102218, China
-
Bekes Varmegyei Kozponti Korhaz Pandy Kalman Tagkorhaz
RECRUITINGGyula, 5700, Hungary
-
CAIR Heidelberg
RECRUITINGHeidelberg, 69121, Germany
-
Centrum Kliniczno Badawcze
RECRUITINGElblag, 82-300, Poland
-
Centrum Medyczne Reuma Park
RECRUITINGWarsaw, 02 665, Poland
-
Changzhou No 2 Peoples Hospital
RECRUITINGChangzhou, 213003, China
-
Charite Universitaetsmedizin Berlin
RECRUITINGBerlin, 10117, Germany
-
Clinical Research Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19114, United States
-
Clinical Research of West Florida
RECRUITINGTampa, Florida, 33606, United States
-
Clintrial s r o
RECRUITINGPrague, 100 00, Czechia
-
Complex Rendelo Med Zrt
RECRUITINGSzékesfehérvár, 8000, Hungary
-
Conquest Research
RECRUITINGWinter Park, Florida, 32789, United States
-
ETG Lublin
RECRUITINGLublin, 20 412, Poland
-
Etyka Osrodek Badan Klinicznych Tomasz Pesta S K A
RECRUITINGOlsztyn, 10 117, Poland
-
Fachklinik Bad Bentheim
RECRUITINGBad Bentheim, 48455, Germany
-
FutureMeds Targowek
RECRUITINGWarsaw, 03 291, Poland
-
Gemeinschaftspraxis Dres. Quist
RECRUITINGMainz, 55128, Germany
-
Hamburger Rheuma Forschungszentrum II
RECRUITINGHamburg, 20095, Germany
-
Hautarztpraxis
RECRUITINGWitten, 58453, Germany
-
Hautarztpraxis Mortazawi
RECRUITINGRemscheid, 42897, Germany
-
Hosp Univ A Coruna
RECRUITINGA Coruña, 15006, Spain
-
Hosp. Clinico Univ. de Santiago
RECRUITINGSantiago de Compostela, 15706, Spain
-
Hosp. Infanta Luisa
RECRUITINGSeville, 41010, Spain
-
Hosp. Virgen Del Rocio
RECRUITINGSeville, 41013, Spain
-
Hosp. Virgen Macarena
RECRUITINGSeville, 41009, Spain
-
Hospital of the University of Occupational and Environmental Health
RECRUITINGKitakyushu-shi, 807-8556, Japan
-
Imamura General Hospital
RECRUITINGKagoshima, 890-0064, Japan
-
Innovation Medical Research Center
RECRUITINGPalmetto Bay, Florida, 33157, United States
-
Integral Rheumatology And Immunology Specialists
RECRUITINGPlantation, Florida, 33324, United States
-
Joint and Muscle Research Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
L K N Arthrocentrum
RECRUITINGHlučín, 748 01, Czechia
-
MICS Centrum Medyczne Torun
RECRUITINGTorun, 87-100, Poland
-
MICS Centrum Medyczne Warszawa
RECRUITINGWarsaw, 00 874, Poland
-
MICS Centrum Medyczne Warszawa 1
RECRUITINGWarsaw, 00-872, Poland
-
Malopolskie Badania Kliniczne Sp z o o
RECRUITINGKrakow, 30-002, Poland
-
Medical Plus Research S R O
RECRUITINGUherské Hradiště, 68601, Czechia
-
NZOZ Lecznica MAK MED S C
RECRUITINGNadarzyn, 05-830, Poland
-
Newport Huntington Medical Group
RECRUITINGHuntington Beach, California, 92648, United States
-
Ningbo medical center lihuili hospital
RECRUITINGNingbo, 315041, China
-
Nzoz Osteo Medic
RECRUITINGBialystok, 15 351, Poland
-
Obudai Egeszsegugyi Centrum Kft
RECRUITINGBudapest, 1036, Hungary
-
Osaka Metropolitan University Hospital
RECRUITINGOsaka, 545 8586, Japan
-
Paramount Medical Research & Consulting
RECRUITINGMiddleburg Heights, Ohio, 44130, United States
-
Peking University People's Hospital
RECRUITINGBeijing, 100044, China
-
Peking University Third Hospital
RECRUITINGBeijing, 100191, China
-
Porcika Klinika - Vasarhelyi Sarkanyfu Kft.
RECRUITINGHódmezővásárhely, 6800, Hungary
-
Pratia Czech A S
RECRUITINGPardubice, 53002, Czechia
-
Pratia MCM Krakow
RECRUITINGKrakow, 30-727, Poland
-
Praxis Mario Sutowicz
RECRUITINGCottbus, 3042, Germany
-
Qualiclinic Kft
RECRUITINGBudapest, 1134, Hungary
-
Qualmedica Research
RECRUITINGEvansville, Indiana, 47715, United States
-
RHEUMA s r o
RECRUITINGBřeclav, 690 02, Czechia
-
Revmatologicka ambulance
RECRUITINGKarvina Frystat, 733 01, Czechia
-
Rheuma Medicus Sp z o o
RECRUITINGWarsaw, 02 118, Poland
-
Rheumatologische Schwerpunktpraxis
RECRUITINGBerlin, 10777, Germany
-
Rheumatology Center of San Diego
RECRUITINGSan Diego, California, 92128, United States
-
Sanuki Municipal Hospital
RECRUITINGSanuki, 769-2393, Japan
-
Semmelweis Egyetem Reumatologiai es Immunologiai Klinika
RECRUITINGBudapest, 1023, Hungary
-
Shanghai Sixth People's Hospital
RECRUITINGShanghai, 200233, China
-
Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy
RECRUITINGBydgoszcz, 85 168, Poland
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, 400016, China
-
The Second Affiliated Hospital of Zhejiang University
RECRUITINGHangzhou, 310009, China
-
Tokito Clinic Rheumatology and Orthopaedic Surgery
RECRUITINGShimonoseki, 752 0976, Japan
-
Tokyo Metropolitan Tama Medical Center
RECRUITINGFuchū, 183 8524, Japan
-
Unity Health-White County Medical Center
RECRUITINGSearcy, Arkansas, 72143, United States
-
Vital Medical Center Orvosi es Fogaszati Kozpont
RECRUITINGVeszprém, 8200, Hungary
-
West China Hospital Sichuan University
RECRUITINGChengdu, 610093, China
-
Willow Rheumatology and Wellness PLLC
RECRUITINGWillowbrook, Illinois, 60527, United States
-
Xiangya Hospital Central South University
RECRUITINGChangsha, 410008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an approved arthritis drug stop early joint damage?
- Nanobody injection put to the test against psoriatic arthritis
- New study to measure drug levels in breast milk of moms on TREMFYA
- New drug shows promise in taming psoriatic arthritis flares
- New injection targets psoriatic arthritis pain in small trial
- New study tracks arthritis drug persistence in daily life